Orchestra BioMed Presents New AVIM Therapy Clinical Data at HRX Demonstrating Substantial and Sustained Blood Pressure Reductions that are Reproducible Upon Reactivation Following Washout
Go back to Orchestra BioMed Presents New AVIM Therapy Clinical Data at HRX Demonstrating Substantial and Sustained Blood Pressure Reductions that are Reproducible Upon Reactivation Following Washout| Medtronic Inc. (NYSE: MDT) | Delayed: 93.35 +1.05 (1.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.30 | 52 Week High | $89.27 | |||
| Open | $92.57 | 52 Week Low | $71.03 | |||
| Day High | $93.55 | P/E | 26.52 | |||
| Day Low | $91.73 | EPS | $3.52 | |||
| Volume | 7,494,709 | |||||
| (NASDAQ: OBIO) | Delayed: 5.36 -0.07 (1.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.43 | 52 Week High | $ | |||
| Open | $5.45 | 52 Week Low | $ | |||
| Day High | $5.53 | P/E | N/A | |||
| Day Low | $5.27 | EPS | $ | |||
| Volume | 276,667 | |||||
